Gf Fund Management Co. Ltd. Ab Cellera Biologics Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 5,882 shares of ABCL stock, worth $21,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,882
Previous 6,429
8.51%
Holding current value
$21,704
Previous $32.3 Million
37.79%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABCL
# of Institutions
160Shares Held
98.2MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$16.8 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...